Title : Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects.

Pub. Date : 2005 Nov

PMID : 16113665






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects. Dexamethasone interleukin 6 Homo sapiens
2 Interleukin-6 (IL-6) is a major survival factor for multiple myeloma (MM) cells preventing apoptosis induced by dexamethasone (DEX) or chemotherapy. Dexamethasone interleukin 6 Homo sapiens
3 Interleukin-6 (IL-6) is a major survival factor for multiple myeloma (MM) cells preventing apoptosis induced by dexamethasone (DEX) or chemotherapy. Dexamethasone interleukin 6 Homo sapiens
4 Interleukin-6 (IL-6) is a major survival factor for multiple myeloma (MM) cells preventing apoptosis induced by dexamethasone (DEX) or chemotherapy. Dexamethasone interleukin 6 Homo sapiens
5 Interleukin-6 (IL-6) is a major survival factor for multiple myeloma (MM) cells preventing apoptosis induced by dexamethasone (DEX) or chemotherapy. Dexamethasone interleukin 6 Homo sapiens